Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elran Haber"'
Autor:
Corinne Maurice-Dror, Osnat Tirosh, Sheerli Kruger Ben-Shabat, Shiri Eshar, Omri Plolonsky, Noa Davis, Elran Haber, Shiri Meshner, Ruth Perets
Publikováno v:
Journal of Clinical Oncology. 40:TPS2685-TPS2685
TPS2685 Background: Immune-Checkpoint inhibitors (ICI) have transformed the treatment of solid tumors, specifically in cutaneous melanoma, clear cell renal cell carcinoma (ccRCC) and non-small cell lung cancer (NSCLC). Despite these advances, a signi
Autor:
Osnat Tirosh, Shiri Meshner, Shiri Eshar, Sheerli Kruger Ben-Shabat, Omri Polonsky, Evyatar Brayer, Elran Haber, Yehuda Ringel
Publikováno v:
Gastroenterology. 162:S-131
Autor:
Sheerli Kruger Ben-Shabat, Omri Polonsky, Elran Haber, Osnat Tirosh, Shiri Meshner, Shiri Eshar, Yehuda Ringel
Publikováno v:
Inflammatory Bowel Diseases. 27:S38-S38
The mechanisms by which the intestinal microbiome affects intestinal inflammation and disease activity in IBD is not clear. Most of the current data on the association between the intestinal microbiome and IBD is focusing on the intestinal microbial
Publikováno v:
Gastroenterology. 158:S-72
Publikováno v:
Gastroenterology. 156:S-1119
Autor:
Haim D. Danenberg, Nickolay Koroukhov, Dikla Gutman, Hila Epstein, Einat Cohen-Sela, Gershon Golomb, Omar Elmalak, Elran Haber
Liposomes containing bisphosphonates have been shown to deplete circulating monocytes and reduce experimental restenosis. However, acceptable shelf life was not achieved, and the disruption extent and rate of the vesicles in the circulation has not b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::284394c9eb29c59ee45135a3e7b970d0
https://europepmc.org/articles/PMC2628204/
https://europepmc.org/articles/PMC2628204/